Affiliation:
1. From the Departments of Pharmacology and Pediatrics, Center for Molecular Therapeutics, College of Physicians and Surgeons of Columbia University, New York, NY.
Abstract
Stem cell research and its clinical application have become political, social, and medical lightning rods, polarizing opinion among members of the lay community and among medical/scientific professionals. A potpourri of opinion, near-anecdotal observation, and scientifically sound data has sown confusion in ways rarely seen in the medical arts and sciences. A major issue is regulation, with different aspects of stem cell research falling within the purview of different government agencies and local offices. An overarching clearinghouse to review the field and recommend policy is lacking. In the following pages, I touch on the societal framework for regulation, the known and potential risks and benefits of cardiovascular stem cell therapies, whether stem cells should be regulated as drugs or in analogy to drugs, and if there is to be regulation, then by whom. In so doing, I refer to the stem cell literature only as it relates to the discussion of regulation because this is not a review of stem cell research; it is an opinion regarding regulation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference61 articles.
1. Stein J Harnick S Bock J. Fiddler on the Roof. New York NY: Crown Publishers; 1964.
2. CNN 2005
3. Bohme G. Cultural resources for coping with technological progress. Jephcott E trans. In: List E Fiala E eds. Grundlagen der Kulturwissenschaften. Tubingen: Interdisziplinare Kulturstudien; 2004.
4. The Regulation of Technology
5. Berg P. Asilomar and recombinant DNA. 2004. Available at: http://nobelprize.org/nobel_prizes/chemistry/articles/berg/index.html. Accessed October 9 2006.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献